3 Reasons This HealthCare Stock Is a Great Buy in 2022
The importance of the healthcare industry became more clear amid the pandemic. With the aging population and the world engulfed with numerous other health crises, this is one sector that isn't losing its relevance any time soon.
Everyone knows Johnson & Johnson's (NYSE: JNJ) brands, including Listerine, Neutrogena, Clean & Clear, Benadryl, and Stayfree, and many more that have captured global market share. But the company is much more than that. Even amid the ongoing pandemic, Johnson & Johnson kept growing its revenue and profits, showing how strong its brand name is and the loyal customer base it has created.
Its recent fourth-quarter 2021 results are proof of its excellent financials. Let's take a look at those numbers and why this stock is a great buy this year.
Source Fool.com
